Rapidly Disseminated Kaposi's Sarcoma Despite Initiation of Antiretroviral Therapy

被引：0

作者：

Saberian, Chantal ^{[1
]}

Campbell, Breanna R. ^{[2
]}

机构：

[1] Baton Rouge Gen, Dept Med, Baton Rouge, LA 70809 USA

[2] Baton Rouge Gen, Dept Infect Dis, Baton Rouge, LA USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 05期

关键词：

aids; hiv; antiretroviral therapy; kaposi's sarcoma; visceral kaposi sarcoma; kshv inflammatory cytokine syndrome (kics); combination antiretroviral therapy; hiv aids; kaposi's sarcoma-associated herpesvirus (kshv); PEGYLATED-LIPOSOMAL DOXORUBICIN;

D O I：

10.7759/cureus.39627

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Kaposi's sarcoma (KS) is the most common malignancy in people living with HIV. The reported incidence of AIDS -related KS has been dramatically decreased with the introduction of antiretroviral therapy (ART). Systemic treatment with ART is indicated for patients with AIDS -related KS; however, some patients may develop KS -related immune reconstitution inflammatory syndrome characterized by sudden rapid progression of new or pre-existing KS within the initiation of ART. Here, we present a case of rapidly disseminated KS with widespread visceral involvement despite ART initiation in a 27 -year -old African American man with advanced HIV/AIDS.

引用

页数：6

共 50 条

[41] Disseminated AIDS-associated Kaposi's sarcoma in pregnancy
Sebitloane, H. M.
Mosam, A.
Moodley, J.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2006, 96 (07): : 602 - 603
[42] Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America
Castilho, Jessica L.
Kim, Ahra
Jenkins, Cathy A.
Grinsztejn, Beatriz
Gotuzzo, Eduardo
Fink, Valeria
Padgett, Denis
Belaunzaran-Zamudio, Pablo F.
Crabtree-Ramirez, Brenda
Escuder, Maria Mercedes
Souza, Rosa Alencar
Tenore, Simone B.
Pimentel, Sidnei R.
Rodrigues Ikeda, Maria Leticia
de Alencastro, Paulo R.
Tupinanbas, Unai
Brites, Carlos
Luz, Estela
Netto, Juliana
Cortes, Claudia P.
Grangeiro, Alexandre
Shepherd, Bryan E.
McGowan, Catherine C.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (01)
[43] Clinical characteristics of HIV-associated Kaposi's sarcoma in the era of combination antiretroviral therapy
Meyer, L.
Stoehr, A.
Horst, H. -A
Plettenberg, A.
Lorenzen, T.
Schewe, K.
Sabranski, M.
Hoffmann, C.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 175 - 175
[44] Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection
Loke, W. C.
Spittle, M. F.
Mitchell, S.
Kulasegaram, R.
INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (08) : 565 - 566
[45] Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma
Alsina, MM
Bulla, F
Conill, C
Mallolas, J
Pérez-Cuevas, JB
Lecha, M
MEDICINA CLINICA, 2000, 115 (19): : 736 - 737
[46] Profile of patients with Kaposi's sarcoma (KS) in the era of highly active antiretroviral therapy (HAART).
Gallafent, JH
Buskin, S
De Turk, P
Aboulafia, DM
BLOOD, 2003, 102 (11) : 280A - 280A
[47] Clinical profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent, JH
Buskin, S
De Turk, R
Aboulafia, DM
JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S157 - S157
[48] Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement
Grabar, Sophie
Abraham, Bruno
Mahamat, Aba
Del Giudice, Pascal
Rosenthal, Eric
Costagliola, Dominique
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3408 - 3414
[49] Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma
Schwartz, JD
Howard, W
Scadden, DT
AIDS, 1999, 13 (02) : 283 - 284
[50] Highly active antiretroviral therapy (HAART) and regression of epidemic pulmonary Kaposi's sarcoma.
Aboulafia, DM
BLOOD, 1997, 90 (10) : 2931 - 2931

← 1 2 3 4 5 →